PER-104-20招募中未知
MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND, CLINICAL TRIAL OF SUPERIORITY IN EFFICACY AND SAFETY OF THE FIXED-DOSE COMBINATION OF AMOXICILLIN AND AMBROXOL (AMBROXIL®) VERSUS AMOXICILLIN IN THE TREATMENT OF ACUTE BACTERIAL PHARYNGOTONSILLITIS IN ADULTS.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •-Patients between 18 - 80 years old
- •-Clinical diagnosis of bacterial pharyngotonsillitis (4 or more criteria of Modified Centor by McIsaac) with rapid antigenic detection test for positive GABHS, or less than 4 criteria of Modified Centor by McIsaac with rapid antigenic detection test for positive GABHS.
- •-Signed informed consent form.
- •-Rapid SARS COV-2 Test Negative
排除标准
- •-Concomitant respiratory infections such as acute otitis media, acute sinusitis, pneumonia, subpharyngeal infections or tonsillar abscesses.
- •- History of rheumatic heart disease or valve dysfunction of unknown etiology
- •- Immunosuppression
- •-Skin rash
- •- Medical history of kidney disease or liver failure.
- •- Patients with some type of cancer.
- •- History of recurrent or recent pharyngotonsillitis (more than 3 episodes in the last 6 months or 1 episode in the last month)
- •- Have received oral antibiotics in the last 7 days prior to enrollment in the study or have received cephalosporins in the last three months.
- •- History of hypersensitivity to amoxicillin or type 1 hypersensitivity to penicillin.
- •- History of hypersensitivity to ambroxol.
- •- Pregnancy or lactation.
- •- Concurrent treatment with another antibiotic or with corticosteroids.
研究者
相似试验
已完成
不适用
MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND CLINICAL TRIAL OF SUPERIORITY IN EFFICACY AND SAFETY OF THE FIXED-DOSE COMBINATION OF AMOXICILLIN AND AMBROXOL (AMBROXIL®) VERSUS AMOXICILLIN IN THE TREATMENT OF ACUTE BACTERIAL PHARYNGITIS IN THE PEDIATRIC POPULATION.PER-062-20Instituto Quimioterapico S.A.,292
招募中
不适用
MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND CLINICAL TRIAL OF SUPERIORITY IN EFFICACY AND SAFETY OF THE FIXED-DOSE COMBINATION OF CEPHALEXIN AND AMBROXOL (BIOBRONCOL®) VERSUS CEPHALEXIN IN THE TREATMENT OF ACUTE BACTERIAL PHARYNGOTONSILLITIS IN ADULTS-J039 Acute tonsillitis, unspecifiedAcute tonsillitis, unspecifiedJ039PER-103-20Instituto Quimioterapico S.A.,25
尚未招募
不适用
MULTICENTER, RANDOMIZED, PARALLEL GROUP, DOUBLE-BLIND CLINICAL TRIAL OF SUPERIORITY IN EFFICACY AND SAFETY OF THE FIXED-DOSE COMBINATION OF CEPHALEXIN AND AMBROXOL (BIOBRONCOL®) VERSUS CEPHALEXIN IN THE TREATMENT OF ACUTE BACTERIAL PHARYNGOTONSILLITIS IN THE PEDIATRIC POPULATION.-J039 Acute tonsillitis, unspecifiedAcute tonsillitis, unspecifiedJ039PER-063-20Instituto Quimioterapico S.A.,179
进行中（未招募）
不适用
Multicenter, Randomized, Parallel-group, Double-blind, Placebo-controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate and Lithium as Monotherapy for up to 104 weeks Maintenance Treatment of Bipolar I Disorder in Adult Patients - SPaRCLeMedDRA version: 9.1Level: LLTClassification code 10004939Term: Bipolar I disorderBipolar I DisorderEUCTR2004-000915-25-LTAstraZeneca R&D Sodertalje2,100
进行中（未招募）
1 期
Clinical trial in several centers in which patients are administrating randomly in parallel with treatment or placebo (control). Neither the researchers nor the patients know which treatment the patiens are receiving. Present clinical trial evaluates safety and clinical efficacy of intradermal immunotherapy with polymerised Phleum pratense, in patients with allergic rhino-conjunctivitis with or without mild to moderate asthma, sensitized to Phleum pratense pollen.Allergic patients to the pollen of Phleum pratense with allergic rhino-conjunctivitis with or without mild to moderate asthma.MedDRA version: 16.1Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisSystem Organ Class: 100000004853EUCTR2014-000429-18-ESDIATER, Laboratorio de Diagnóstico y Aplicaciones Terapéuticas, S.A.174